Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market
Holding ELEV?
Track your performance easily

Elevation Oncology (ELEV) Financial Statements

276 Followers

Elevation Oncology Financial Overview

Elevation Oncology's market cap is currently ―. The company's EPS TTM is $-0.807; its P/E ratio is -0.80; Elevation Oncology is scheduled to report earnings on May 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -12.87M$ -10.45M$ -9.87M$ -9.08M$ -10.92M
EBITDA$ -12.86M$ -10.17M$ -9.86M$ -9.07M$ -10.91M
Net Income Common Stockholders$ -12.88M$ -10.46M$ -10.71M$ -7.90M$ -10.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 103.07M$ 110.85M$ 104.05M$ 83.11M$ 94.80M
Total Assets$ 106.30M$ 114.60M$ 108.96M$ 89.09M$ 99.97M
Total Debt$ 31.02M$ 30.92M$ 30.81M$ 30.14M$ 29.95M
Net Debt$ -72.05M$ -79.93M$ -73.24M$ -52.97M$ -64.84M
Total Liabilities$ 36.95M$ 33.68M$ 33.14M$ 34.28M$ 37.56M
Stockholders Equity$ 69.36M$ 80.96M$ 75.82M$ 54.81M$ 62.42M
Cash Flow-
Free Cash Flow$ -8.38M$ -8.21M$ -9.57M$ -12.18M$ -13.36M
Operating Cash Flow$ -8.38M$ -8.21M$ -9.57M$ -12.18M$ -13.36M
Investing Cash Flow$ -2.87M$ -37.66M$ 20.70M$ 6.56M$ -38.12M
Financing Cash Flow$ 10.00K$ 14.68M$ 30.25M$ -2.00K$ 27.00K
Currency in USD

Elevation Oncology Earnings and Revenue History

Elevation Oncology Debt to Assets

Elevation Oncology Cash Flow

Elevation Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis